2019 has got off to a bumper start for BES, with new contracts won by our Southern office alone totalling £6.7 million. It shows that our expansion in Milton Keynes, where our clients, team and delivery partners in the South can collaborate in a shared space at our offices while tapping into our national capabilities, is already building on the success of our Rochdale HQ across the pharmaceutical, biotech and medical sectors.
We have recently appointed a new Design Lead, Darren Wolfe to join our growing team in Milton Keynes office. The company has experienced substantial business growth over the last few years and opened the second office to facilitate further expansion and respond more quickly to the needs of our southern clients. In his role, Darren, will be responsible for building relationships with our clients, establishing their requirements and advising on the best solutions. He will be also overseeing project delivery from feasibility studies to handover and completion.
Following the successful delivery of a new R&D facility for the world leader in addiction treatment, BES were awarded a £500,000 commission to design a new oral solid dose manufacturing facility, located on the same site. Following an initial feasibility study to establish the project requirements, our Front End design team worked closely with the client from project inception to develop the design up to RIBA Stage 3.
Our new client, specialising in development of new applications for patch technology, engaged BES to undertake a front end study to understand the feasibility of locating a new IMP pilot manufacturing plant within their existing building. Our feasibility study demonstrated that the existing building could be re-modelled to form a new clinical trials facility.
Following completion of the structural slab and steelwork installations, the site is now prepared to commence the internal fit out activities, with Norwood leading the way with the innovative, highly specified, pre-fabricated partitioning system. The facility will occupy a total floor area in excess of 7,500m2 and comprises individual Primary Packing rooms with large, common secondary Packing areas.To meet the specific requirements of this qualified facility, bespoke solutions have been designed and developed.
Early cancer diagnosis, research and treatment have advanced exponentially in recent years, improving patient outcomes. As our understanding of cancer develops and treatments become increasingly sophisticated, there is a need to custom-prepare medication to meet the specific needs of the patient and their condition. This, in turn, demands increasingly sophisticated production facilities, both in the pharmaceutical manufacturing sector and in hospital environments, where biopharma best practice can provide key learnings for safe, effective and energy-efficient drug preparation suites within the healthcare campus.
To conclude the 'Meet Our Design Team' campaign, we would like to present an interview with our BIM Manager, Mike Robinson. Mike is the focal point of development, implementation and monitoring of the use of BIM at BES. His primary responsibility is to manage and coordinate BIM standards on all related projects, files and models. He works closely with the Design Director and Principal Architect to help guide the implementation of BIM improvement strategy across the company and provides training to new staff, as well as updates our existing employees on the latest BIM protocols and procedures. In his interview, Mike explains what he finds exciting about his role and what aspect of his work is the most challenging at the moment.
Ours is a skill- and knowledge-based business so, although our design, engineering and construction teams are highly qualified, we are still investing heavily in training. However, most of our investment is dedicated to leadership and Personal Effectiveness with over 50% of our employees having now undergone our tailored leadership programme.
Medical research has achieved some extraordinary breakthroughs over the past few years and collaboration between clinicians, researchers and the pharmaceutical sector means that effective treatments are improving outcomes for patients faster than ever. The use of HPAPI (high potency active pharmaceutical ingredients), often highly toxic compounds that target unhealthy cells without damaging healthy cells, has become an area of huge potential for innovation.
As a continuation of the 'Meet our design team' campaign, we'd like to present a short interview with another key member of BES team, our Architecture Subject Matter Expert, Graham Pomfret. Graham has over 40 years experience in the construction industry, initially working for a number of architectural practices in the North West before moving into the pharmaceutical/healthcare sector over 25 years ago. He works closely with clients to develop and finalise the facility layout, material/personnel flows and finishes, and alongside the BES multi-disciplined design team through to construction to ensure that value management and quality assurance processes were applied to the project. Graham has an in-depth knowledge of pharmaceutical and healthcare facilities coupled with a strong technical background in construction.